Does Tumor FDG-PET-Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Kernstine KH, Faubert B, Do QN, Rogers TJ, Hensley CT, Cai L, Torrealba J, Oliver D, Waschmann JW, Lenkinski RE, Malloy CR, Deberardinis RJ., Ann Thorac Surg. () 2019 Dec 14. pii: S0003-4975(19)31875-2. doi: 10.1016/j.athoracsur.2019.10.061. [Epub ahead of print], 2020International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions. (2020) The IAS...
Edwards JG, Chansky K, Van Schil P, Nicholson AG, Boubia S, Brambilla E, Donington J, Galateau-Sallé F, Hoffmann H, Infante M, Marino M, Marom EM, Nakajima J, Ostrowsk..., J Thorac Oncol. () 2020 Mar;15(3):344-359. doi: 10.1016/j.jtho.2019.10.019. Epub 2019 Nov 13., 2020Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus o...
Von Itzstein MS, Gupta A, Kernstine KH, Mara KC, Khanna S, Gerber DE., PloS one. 2020;15(4):e0231258., 2020
